Truth in Health Joins Patients1st Coalition & MAHA
Truth in Health joins the Patients1st Coalition, helping bridge science, prevention, and public health conversations shaping America’s future.
Truth in Health joins the Patients1st Coalition, helping bridge science, prevention, and public health conversations shaping America’s future.
Global Omega Balance Open Letter
Scientists, clinicians and researchers from around the world are calling for greater attention to the balance of omega-3 and omega-6 fatty acids in the modern food supply and their relationship to human health.
Truth in Health Association is helping bring these voices together through an open scientific statement calling for continued research, professional education, public awareness and coordinated scientific review.
Why This Matters
Omega-3 and omega-6 fatty acids are both essential nutrients, but changes in agriculture, food processing, animal feeds and dietary patterns have altered the fatty acid composition of the modern food supply.
Researchers continue to investigate what those changes mean for inflammation, metabolism, neurological development, cardiovascular health, the endocannabinoid system and other areas of human physiology. The purpose of this initiative is to encourage rigorous scientific attention to those questions.
The scientific statement recognizes areas of established knowledge as well as questions that remain under active scientific discussion. Its purpose is not to label a single nutrient as good or bad, but to encourage transparent assessment of how modern dietary patterns and food systems may influence essential fatty acid exposure and human biology.
Scientific Community
Continue investigating essential fatty acid exposure, biomarkers, biological effects and health outcomes.
Health Professionals
Strengthen professional education and awareness around essential fatty acids and their physiological roles.
Public Institutions
Support transparent scientific review, better data and evidence-informed public-health discussion.
Read. Review. Participate.
Review the statement, explore the scientific considerations and see the researchers and clinicians who have added their names to the initiative.
Scientific Statement
To Heads of State, Ministers of Health, Directors of International and Regional Health Agencies, and Leaders of Global Food and Agriculture Systems:
We, the undersigned scientists and clinicians working in lipid biology, nutrition, metabolism, developmental neuroscience, resolution pharmacology, and the endocannabinoid system, write to draw your attention to a critical but addressable aspect of modern human nutrition: the altered intake and biological handling of essential fatty acids, particularly omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), and their impact on human physiology across the life course.
Our aim is not to declare a simple “villain” nutrient, but to underscore that current dietary patterns and food systems have created a biochemical milieu without historical precedent, and that this milieu may have important implications for inflammation, neurodevelopment, cardiometabolic disease, and healthy aging. We believe this warrants coordinated national and international assessment, guidance, and education.
Established Foundations
There is broad scientific agreement that:
Essential fatty acids participate in:
When intake patterns and tissue composition of these fatty acids are substantially shifted—whether by high LA intake, low EPA/DHA intake, altered animal feeds, or ultra-processed dietary patterns—there is concern that inflammatory responses, neurodevelopmental trajectories, and cardiometabolic risk profiles may be negatively affected.
These issues affect educational attainment, workforce productivity, and long-term health expenditure trajectories of every nation.
Scientific Transparency
The undersigned acknowledge ongoing scientific debate, including:
These open questions strengthen rather than weaken the case for coordinated action. They highlight how much is at stake and how much clarity is still needed.
Recommended Action
1. Establish National Essential Fatty Acid Committees or Task Forces
Mandated to review current intakes, tissue levels, and health outcomes related to key fatty acids, with representation from lipid biochemistry, clinical nutrition, pediatrics, neurology, psychiatry, cardiometabolism, immunology, and public health.
2. Conduct Comprehensive National and Regional Assessments
Map dietary intakes; assess biomarkers; evaluate associations with cardiovascular disease, diabetes, obesity, autoimmune and inflammatory conditions, neurodevelopmental and neurodegenerative disorders, and mental health.
3. Develop Evidence-Based Guidance for Food Systems and Agriculture
Review how agricultural policies, animal feeds, and food processing affect population exposures to specific fatty acids; consider improvements for long-chain omega-3 intake.
4. Integrate Essential Fatty Acids into Health Professional Education
Ensure medical, nursing, dietetic, and public-health training includes robust coverage of fatty acids and their physiological roles.
5. Support Research on Individual Fatty Acids and Lifespan Needs
Fund mechanistic and clinical research; clarify age-specific requirements; improve methods for tissue-level lipid assessment.
6. Collaborate Through International Platforms
Utilize WHO, FAO, UNICEF, and other agencies to harmonize data and develop guidance.
A Call for Leadership
This statement is not a call for simplistic dietary prescriptions or for blaming any single nutrient. It is a call for recognition that modern fatty acid patterns differ substantially from those that shaped human physiology; for transparent assessment of their relationship to disease burden and human potential; and for leadership in aligning agriculture, food policy, and health systems with biological needs.
The potential gains in health, cognition, resilience, and national prosperity could be generational.
Respectfully,
Charles “Chip” Paul
ECS Theorist & Public Health Advocate
Convenor, Global Scientific Statement on Essential Fatty Acids,
Lipid Composition & Human Health
Prof. Philip C. Calder, PhD, RNutr, FSB, FAfN
Professor of Nutritional Immunology
Faculty of Medicine
University of Southampton
Southampton, United Kingdom
Hagler Fellow
College of Medicine
Texas A&M University
College Station, Texas, USA
Prof. Michael A. Crawford, PhD, FRSB, FRSC, FRCPath
Visiting Professor, Department of Metabolism, Digestion and Reproduction
Chelsea & Westminster Hospital Campus
Imperial College London
United Kingdom
Prof. Jesmond Dalli, PhD, FHEA, FRSB, FBPhS
Professor of Molecular Pharmacology
Director, Lipid Mediator Unit
William Harvey Research Institute
Barts and The London School of Medicine and Dentistry
Queen Mary University of London
United Kingdom
Prof. Vincenzo Di Marzo, PhD
Canada Excellence Research Chair, Microbiome–Endocannabinoidome Axis in Metabolic Health
Université Laval, Quebec, Canada
Research Director, Institute of Biomolecular Chemistry
Consiglio Nazionale delle Ricerche (CNR), Italy
Prof. Jörg (Jürg) Gertsch, PhD
Professor, Institute of Biochemistry and Molecular Medicine
University of Bern
Switzerland
Prof. William S. Harris, PhD
Founder and President, Fatty Acid Research Institute
Professor of Medicine (Emeritus), Sanford School of Medicine
University of South Dakota
United States
Prof. Daniele Piomelli, PhD, MD (h.c.)
Distinguished Professor of Anatomy & Neurobiology, Biological Chemistry, and Pharmaceutical Sciences
Louise Turner Arnold Chair in the Neurosciences
Director, Center for the Study of Cannabis
University of California, Irvine
United States
Adjunct Professor
University of Vienna
Austria
Prof. Charles N. Serhan, PhD, DSc
Gelman Professor of Anaesthesia (Biochemistry & Molecular Pharmacology)
Director, Center for Experimental Therapeutics and Reperfusion Injury
Brigham and Women’s Hospital
Harvard Medical School
United States
Prof. Clemens von Schacky, MD
Chief Executive Officer, Omegametrix GmbH
Senior Researcher in Preventive Cardiology and Lipidomics
Munich, Germany
Add Your Voice
Scientists, physicians, clinicians, researchers, academics and other credentialed health and scientific professionals are invited to review the statement and consider adding their names in support of continued scientific investigation, professional education and evidence-informed discussion around essential fatty acids and human health.
Professional credentials and affiliation will be included with accepted signatories. Submitted information may be reviewed before a name is added to the public signatory list or included with future submissions of this scientific statement.
SIGN THE OPEN LETTER